BOSTON – How will machine learning, precision medicine and artificial intelligence (AI) affect the future of treatments? That question helped frame a panel discussion at the BIO International Convention. Much of the discussion focused on data being collected. "We talk about real-world data, and this is a buzzword," said Scott Solomon, the Edward D. Frohlich distinguished chair, professor of medicine at Harvard Medical School. He added that most real-world data are not very good, and an effort must be made to improve the quality.